RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/15842729http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/15842729http://www.w3.org/2000/01/rdf-schema#comment"

Background

The Major Histocompatibility Complex is the main genetic contributor to susceptibility to type 1 diabetes (T1D); genome-wide scans have consistently mapped increased predisposition to this region. The highest disease risk has been associated with HLA-DR3 and HLA-DR4. In particular, the DR3-positive ancestral haplotype 18.2 was reported as highly diabetogenic. We aimed to corroborate whether this haplotype increases the susceptibility conferred by the DQ2-DR3 alleles in a Mediterranean population. We also searched for additional susceptibility factors to the classic DQ2-DR3 and DQ8-DR4.

Results

Genetic MHC markers were analysed in a case-control study with 302 T1D patients and 529 ethnically matched controls. DR3-TNFa1b5 carrier rate was significantly higher in DR3-positive heterozygous T1D patients than in DR3-positive heterozygous controls (p = 0.0019; odds ratio OR [95% confidence interval CI] = 2.26 [1.3-3.93]). This data was confirmed analysing the allelic frequency, which includes the information corresponding to the DR3-homozygous individuals (p = 0.001; OR = 2.09) and by using the Arlequin software to check the DR3-positive haplotypes (p = 0.004;OR = 1.93). The present results provide strong evidence of a second susceptibility region in the ancestral haplotype 18.2 in the Spanish population. Moreover, we searched for T1D susceptibility factors in addition to the MHC classical ones, within the DR2-DQ6/DR3-DQ2/DR4-DQ8 negative population. Several genetic markers in both MHC class II (DQA1*0101-DQB1*0501 [p = 0.007;OR = 2.81], DQA1*0201-DQB1*0202 [p = 0.03; OR = 2.35]) and III (TNFa2b1 [p = 0.01 OR = 2.74], BAT-2*2 [p = 0.004; OR = 3.19]) were found. These different alleles associated with T1D were not independent and we observed linkage disequilibrium among them leading us to describe two new risk haplotypes (DQA1*0101-DQB1*0501-TNFa2b1 and DQA1*0201-DQB1*0202-BAT-2*2). Finally, we studied a T1D susceptibility/protection marker located in extended class I, D6S2223; however, no association was observed in our population.

Conclusion

Our results suggest that other associated MHC haplotypes might present susceptibility factors in loci different from HLA-class II and that the class II molecules are not necessarily the universal etiologic factor in every MHC haplotype."xsd:string
http://purl.uniprot.org/citations/15842729http://purl.org/dc/terms/identifier"doi:10.1186/1471-2164-6-56"xsd:string
http://purl.uniprot.org/citations/15842729http://purl.uniprot.org/core/author"Martinez A."xsd:string
http://purl.uniprot.org/citations/15842729http://purl.uniprot.org/core/author"Mendez J."xsd:string
http://purl.uniprot.org/citations/15842729http://purl.uniprot.org/core/author"Urcelay E."xsd:string
http://purl.uniprot.org/citations/15842729http://purl.uniprot.org/core/author"de la Concha E.G."xsd:string
http://purl.uniprot.org/citations/15842729http://purl.uniprot.org/core/author"Santiago J.L."xsd:string
http://purl.uniprot.org/citations/15842729http://purl.uniprot.org/core/author"Fernandez-Arquero M."xsd:string
http://purl.uniprot.org/citations/15842729http://purl.uniprot.org/core/author"Maluenda C."xsd:string
http://purl.uniprot.org/citations/15842729http://purl.uniprot.org/core/author"de la Calle H."xsd:string
http://purl.uniprot.org/citations/15842729http://purl.uniprot.org/core/author"Ibarra J.M."xsd:string
http://purl.uniprot.org/citations/15842729http://purl.uniprot.org/core/date"2005"xsd:gYear
http://purl.uniprot.org/citations/15842729http://purl.uniprot.org/core/name"BMC Genomics"xsd:string
http://purl.uniprot.org/citations/15842729http://purl.uniprot.org/core/pages"56"xsd:string
http://purl.uniprot.org/citations/15842729http://purl.uniprot.org/core/title"Type 1 diabetes in the Spanish population: additional factors to class II HLA-DR3 and -DR4."xsd:string
http://purl.uniprot.org/citations/15842729http://purl.uniprot.org/core/volume"6"xsd:string
http://purl.uniprot.org/citations/15842729http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/15842729
http://purl.uniprot.org/citations/15842729http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/15842729
http://purl.uniprot.org/uniprot/#_A0A0E3DC97-mappedCitation-15842729http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/15842729
http://purl.uniprot.org/uniprot/#_A0A0E3DC99-mappedCitation-15842729http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/15842729
http://purl.uniprot.org/uniprot/#_A0A076L4M5-mappedCitation-15842729http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/15842729
http://purl.uniprot.org/uniprot/#_A0A0A7C7I5-mappedCitation-15842729http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/15842729
http://purl.uniprot.org/uniprot/#_A0A0A7C853-mappedCitation-15842729http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/15842729
http://purl.uniprot.org/uniprot/#_A0A0A7CAC7-mappedCitation-15842729http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/15842729